AbbVie (ABBV) closed at $141.21 in the latest trading session, marking a -1.29% move from the prior day.
A little-known group of Buffett stocks includes three members of dividend royalty with solid growth prospects.
Drugmaker AbbVie (NYSE: ABBV) is one of the largest healthcare stocks in the world, with a market cap of over $250 billion. AbbVie last reported its earnings in July. Humira remains key to AbbVie's business for now, generating $5.4 billion this past quarter, nearly three times the $1.8 billion Skyrizi and Rinvoq generated.